Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AIM ImmunoTech Inc.AIM · Entity 8131 | COO, Secretary, Gen. Counsel | April 04, 2025 | April 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AIM ImmunoTech Inc.
Report date April 04, 2025 · Filed April 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 401,762 |
Reported balance
After 2025-04-04 transaction · row 1
1 source rowRow 1 · 2025-04-04 · Purchase · Acquired 500 · Balance 401,762 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2025 Filed Apr 4, 2025 21:19 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 500 | $0.09 | $43.50 |
DisclosureSEC source: 0001641172-25-002827 · ownership.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,762 Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 01:41 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 188,679 | $0.27 | $49,999.94 |
DisclosureSEC source: 0001493152-24-031416 · ownership.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,262 Read SEC document |
| May 06, 2024 Filed May 7, 2024 12:30 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 30,865 | $0.41 | $12,500.33 |
DisclosureSEC source: 0001493152-24-018028 · ownership.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,583 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 19:01 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 37,879 | $0.33 | $12,500.07 |
DisclosureSEC source: 0001493152-24-010268 · ownership.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,718 Read SEC document |
| November 30, 2023 Filed Mar 27, 2024 17:54 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 100,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001493152-24-011465 · ownership.xml · derivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-11-30 Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 12:30 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 80,646 | $0.31 | $25,000.26 |
DisclosureSEC source: 0001493152-23-000213 · ownership.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,839 Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:50 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 100,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001493152-22-034329 · ownership.xml · derivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-30 F1 · security: Options issued pursuant to employment agreement with Reporting Person. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 12:42 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 4,902 | $1.02 | $5,000.04 |
DisclosureSEC source: 0001450324-22-000003 · primary_doc.xml · nonDerivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,193 Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 18:52 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001583701-22-000001 · primary_doc.xml · derivative · entry 1 Rodino Peter W III · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-03-03 Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 20:25 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001788908-21-000003 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · COO,Secretary,Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-30 Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 14:32 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 75,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001788908-20-000002 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · COO, Secretary, Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-12-09 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 16:07 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 6,879 | $0.53 | $3,645.87 |
DisclosureSEC source: 0001450324-20-000002 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,290 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 14:40 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 8,381 | $0.44 | $3,645.74 |
DisclosureSEC source: 0001450324-19-000029 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,411 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 17:09 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 9,115 | $0.40 | $3,646.00 |
DisclosureSEC source: 0001450324-19-000024 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,030 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 19:51 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 7,752 | $0.47 | $3,643.44 |
DisclosureSEC source: 0001450324-19-000019 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,915 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| October 31, 2019 Filed Oct 31, 2019 18:16 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 7,297 | $0.50 | $3,648.50 |
DisclosureSEC source: 0001583701-19-000006 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,163 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:42 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 6,286 | $0.58 | $3,645.88 |
DisclosureSEC source: 0001450324-19-000014 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,866 F1 · kind: Common Stock Award. Vests in six months, provided continuous employment. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 15:04 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 8,695 | $4.03 | $35,040.85 |
DisclosureSEC source: 0001702626-19-000004 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,590 F1 · balance_after: Previous Balance of the amount of securities owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019. Read SEC document |
| May 08, 2019 Filed Jun 17, 2019 19:53 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 63,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613377-19-000005 · primary_doc.xml · nonDerivative · entry 2 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares. Read SEC document |
| March 18, 2019 Filed Jun 17, 2019 19:53 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 90,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613377-19-000005 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the 18 shares issued. Read SEC document |
| February 27, 2019 Filed Mar 13, 2019 15:27 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSubr Rights(to buy) · Derivative | 18 | $1,000.00 Strike: $1,000.00 | $18,000.00 |
DisclosureSEC source: 0001583701-19-000001 · primary_doc.xml · derivative · entry 3 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Pref Stk/Warrants · Not disclosed shares Expires 2019-03-05 F1 · derivative.underlying: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F2 · derivative.underlying: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · derivative.underlying_shares: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| February 27, 2019 Filed Mar 13, 2019 15:27 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherWarrants | 90,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000001 · primary_doc.xml · nonDerivative · entry 2 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F2 · security: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · shares: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · price: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| February 27, 2019 Filed Mar 13, 2019 15:27 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSeries B Convertible Preferred Stock | 18 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000001 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18 F1 · security: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · shares: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · price: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 16:24 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 198,864 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001450324-19-000004 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,864 Underlying: Common Stock · 198,864 shares Expires 2029-01-28 F1 · security: This option is being issued to senior management for a voluntary 50% deferral in salary. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:05 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001613377-18-000037 · primary_doc.xml · nonDerivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,373 F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 17:16 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 1,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001613377-18-000032 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2028-11-14 F1 · security: This option has been awarded by the Board of Directors. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 16:46 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 132,576 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001613377-18-000025 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,576 Underlying: Common Stock · 132,576 shares Expires 2028-10-17 F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary. Read SEC document |
| July 18, 2018 Filed Jul 19, 2018 17:50 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 75,269 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001613377-18-000013 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,269 Underlying: Common Stock · 75,269 shares Expires 2028-07-18 F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:35 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 116,667 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001613377-18-000008 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,667 Underlying: Common Stock · 116,667 shares Expires 2028-05-16 F1 · security: This option is being issued to Senior Management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| April 12, 2018 Filed Apr 19, 2018 18:09 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 100,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001465652-18-000005 · primary_doc.xml · derivative · entry 1 RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-04-12 F1 · security: This option is being awarded by the Board of Directors. Read SEC document |
| February 13, 2018 Filed Mar 1, 2018 18:04 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 173,423 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001613377-18-000003 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,423 Underlying: Common Stock · 173,423 shares Expires 2028-02-13 F1 · security: This option is being issued by senior management in exchange for a voluntary 40% deferral in salary. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 17:40 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 11,416 | $0.26 Strike: $0.36 | $2,968.16 |
DisclosureSEC source: 0001613377-17-000041 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,416 Underlying: Common Stock · 11,416 shares Expires 2027-08-31 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 17:00 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 9,957 | $0.29 Strike: $0.41 | $2,887.53 |
DisclosureSEC source: 0001613377-17-000036 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,957 Underlying: Common Stock · 9,957 shares Expires 2027-08-15 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 16:50 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 9,700 | $0.30 Strike: $0.42 | $2,910.00 |
DisclosureSEC source: 0001613377-17-000029 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,700 Underlying: Common Stock · 9,700 shares Expires 2027-07-31 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| July 15, 2017 Filed Jul 17, 2017 20:35 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 8,458 | $0.34 Strike: $0.48 | $2,875.72 |
DisclosureSEC source: 0001613377-17-000024 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,458 Underlying: Common Stock · 8,458 shares Expires 2027-07-15 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 17:40 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 6,633 | $0.44 Strike: $0.49 | $2,918.52 |
DisclosureSEC source: 0001613377-17-000018 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Sectry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,633 Underlying: Common Stock · 6,633 shares Expires 2027-06-30 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 20:38 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 6,671 | $0.44 Strike: $0.54 | $2,935.24 |
DisclosureSEC source: 0001613377-17-000009 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Secrty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,671 Underlying: Common Stock · 6,671 shares Expires 2027-06-15 F1 · security: This option is being issued in exchange for a voluntary 20% deduction in salary. F1 · price: This option is being issued in exchange for a voluntary 20% deduction in salary. Read SEC document |
| June 15, 2017 Filed Jun 29, 2017 17:32 UTC Amendment | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 6,632 | $0.44 Strike: $0.49 | $2,918.08 |
DisclosureSEC source: 0001613377-17-000013 · primary_doc.xml · derivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Secrty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,632 Underlying: Common stock · 6,632 shares Expires 2027-06-15 F1 · security: Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017. F1 · price: Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017. Read SEC document |
| May 02, 2017 Filed May 3, 2017 16:50 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 15,873 | $0.63 | $9,999.99 |
DisclosureSEC source: 0001583701-17-000001 · primary_doc.xml · nonDerivative · entry 1 Rodino Peter W. III · CIK 0001583701 · Exec Dir Govt Relations/Secrty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,873 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.